SCHEMBL19904427

SCHEMBL19904427

O=C(NC(Cc1cc(F)c2c(c1)OCCO2)CN1CCCC1)C1CCN(c2ccc(Cl)cc2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.38
NOTUM Q6P988 2/20 0.38
HTR1A P08908 1/20 0.37
CCR1 P32246 1/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PROKR2 Q8NFJ6 1/20 0.35
UGCG Q16739 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
MAPT P10636 1/20 0.34
KDM4E B2RXH2 2/20 0.34
DRD2 P14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904551 0.99 HTR1A (0.38) KMT2ANOTUMHTR1ACCR1TSHR
SCHEMBL19904368 0.99 HTR1A (0.38) KMT2ANOTUMHTR1ACCR1TSHR
SCHEMBL19904488 0.98 KMT2A (0.38) KMT2ANOTUMHTR1ACCR1TSHR
SCHEMBL19904542 0.94 UGCG (0.40) KMT2ANOTUMHTR1ATSHRMAPK1
SCHEMBL19904389 0.94 UGCG (0.40) KMT2ANOTUMHTR1ATSHRMAPK1
SCHEMBL19904455 0.92 KMT2A (0.36) KMT2ANOTUMHTR1AMAPK1ALDH1A1
SCHEMBL19904590 0.92 KMT2A (0.36) KMT2ANOTUMHTR1AMAPK1ALDH1A1
SCHEMBL19904506 0.90 TRPV1 (0.39) NOTUMHTR1ATSHRMAPK1USP2
SCHEMBL19904550 0.89 UGCG (0.35) NOTUMHTR1ATSHRMAPK1USP2
SCHEMBL19904561 0.89 MCHR1 (0.36) HTR1AUGCGHDAC4CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed